Skip to main content
Premium Trial:

Request an Annual Quote

Alison Hannah, Lynn Tetrault

NeoGenomics announced the election of Alison Hannah and Lynn Tetrault to its board. Hannah has more than 25 years of experience in developing investigational cancer chemotherapies and has been a consultant to the pharma industry since 2000. She previously was senior medical director at Sugen. She will serve on NeoGenomics' compliance committee. 

Tetrault is a consultant to healthcare companies and is a director of Women's Way. She was at AstraZeneca between 1993 and 2014 and was most recently its executive vice president of HR and corporate affairs. She will chair NeoGenomics' nominating and governance committee and will be a member of the compensation committee. 

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.